| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
361 |
336 |
$9K |
| 80053 |
Comprehensive metabolic panel |
463 |
429 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
59 |
49 |
$849.55 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
22 |
16 |
$837.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
22 |
21 |
$818.29 |
| 84443 |
Thyroid stimulating hormone (TSH) |
354 |
329 |
$750.73 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
367 |
329 |
$393.42 |
| 80074 |
|
14 |
14 |
$333.19 |
| 82607 |
|
139 |
137 |
$257.67 |
| 36415 |
Collection of venous blood by venipuncture |
120 |
110 |
$179.72 |
| 83735 |
|
274 |
254 |
$158.33 |
| 81003 |
|
392 |
272 |
$150.15 |
| 84480 |
|
21 |
13 |
$87.14 |
| 84703 |
|
86 |
83 |
$57.87 |
| 84439 |
|
22 |
14 |
$55.33 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
22 |
21 |
$19.03 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14 |
12 |
$13.86 |
| 80061 |
Lipid panel |
15 |
13 |
$0.00 |